2022. Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice. The Iraqi Journal of Veterinary Medicine. 46, 2 (Dec. 2022), 53–65. DOI:https://doi.org/10.30539/ijvm.v46i2.1554.